Brief: Blue Water Biotech Acquires Proteomedix

Onconetix

18/12/2023 12:09

Dec 18 (Reuters) - Blue Water Biotech Inc  BWV.O :
    * BLUE WATER BIOTECH ACQUIRES PROTEOMEDIX AS PART OF
TRANSFORMATION TO COMMERCIAL STAGE ONCOLOGY COMPANY; ANNOUNCES
NAME CHANGE TO ONCONETIX™
    * BLUE WATER BIOTECH: ACQUISITION OF PROTEOMEDIX FOR ALL
STOCK
CONSIDERATION PROVIDES ITS SHAREHOLDERS WITH INITIAL 19.9%
OWNERSHIP STAKE OF ONCONETIX

Source text for Eikon:  ID:nGNXbnBM8t 
Further company coverage:  BWV.O 

 ((Reuters.Briefs@thomsonreuters.com;))